Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours.

Srirajaskanthan R, Ahmed A, Prachialias A, Srinivasan P, Heaton N, Jervis N, Quaglia A, Vivian G, Ramage JK.

ISRN Oncol. 2013;2013:420795. doi: 10.1155/2013/420795. Epub 2013 Feb 28.

2.

TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.

Yang M, Zeng L, Zhang Y, Wang WG, Wang L, Ke NW, Liu XB, Tian BL.

Medicine (Baltimore). 2015 Mar;94(12):e660. doi: 10.1097/MD.0000000000000660.

3.
4.

Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.

Strosberg JR, Cheema A, Weber JM, Ghayouri M, Han G, Hodul PJ, Kvols LK.

Ann Surg. 2012 Aug;256(2):321-5. doi: 10.1097/SLA.0b013e31824e6108.

PMID:
22415420
5.

Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.

Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R, Panzuto F, Pederzoli P, delle Fave G, Falconi M.

Mod Pathol. 2010 Jun;23(6):824-33. doi: 10.1038/modpathol.2010.58. Epub 2010 Mar 19.

6.

Clinical and prognostic features of rectal neuroendocrine tumors.

Weinstock B, Ward SC, Harpaz N, Warner RR, Itzkowitz S, Kim MK.

Neuroendocrinology. 2013;98(3):180-7. doi: 10.1159/000355612. Epub 2013 Nov 5.

7.

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.

Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B.

Cancer. 2008 Jul 15;113(2):256-65. doi: 10.1002/cncr.23549.

8.

Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.

Clift AK, Faiz O, Goldin R, Martin J, Wasan H, Liedke MO, Schloericke E, Malczewska A, Rindi G, Kidd M, Modlin IM, Frilling A.

Endocr Connect. 2017 Feb;6(2):71-81. doi: 10.1530/EC-16-0114. Epub 2017 Jan 19.

9.

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B.

J Natl Cancer Inst. 2012 May 16;104(10):764-77. doi: 10.1093/jnci/djs208. Epub 2012 Apr 23.

PMID:
22525418
10.

Pathology - grading and staging of GEP-NETs.

Capelli P, Fassan M, Scarpa A.

Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):705-17. doi: 10.1016/j.bpg.2013.01.003. Review.

PMID:
23582914
11.

Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems.

Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN.

Ann Surg Oncol. 2013 Apr;20(4):1170-8. doi: 10.1245/s10434-012-2746-z. Epub 2012 Dec 1.

PMID:
23212760
12.

Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models.

Dolcetta-Capuzzo A, Villa V, Albarello L, Franchi GM, Gemma M, Scavini M, Di Palo S, Orsenigo E, Bosi E, Doglioni C, Manzoni MF.

Cancer. 2013 Jan 1;119(1):36-44. doi: 10.1002/cncr.27716. Epub 2012 Jun 28.

13.

[Neuroendocrine tumours of the GI tract--data from the German NET Registry].

Begum N, Maasberg S, Plöckinger U, Anlauf M, Rinke A, Pöpperl G, Lehnert H, Izbicki JR, Krausch M, Vashist YK, Raffel A, Bürk CG, Hoffmann J, Goretzki P, Pape UF; Weitere Vertreter des deutschen NET-Registers..

Zentralbl Chir. 2014 Jun;139(3):276-83. doi: 10.1055/s-0032-1315199. Epub 2012 Oct 5. German.

PMID:
23042103
14.
15.

Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.

Zandee WT, Kamp K, van Adrichem RC, Feelders RA, de Herder WW.

Eur J Endocrinol. 2016 Nov;175(5):361-6. doi: 10.1530/EJE-16-0392. Epub 2016 Aug 4.

PMID:
27491374
16.

Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis.

Dumitrascu T, Dima S, Herlea V, Tomulescu V, Ionescu M, Popescu I.

Langenbecks Arch Surg. 2012 Aug;397(6):933-43. doi: 10.1007/s00423-012-0951-7. Epub 2012 Apr 3.

17.
18.

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA.

BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11.

19.

[Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].

Shi GD, Luo ZL, Fu MY, Tian D, Zhang L, Zhang KP.

Zhonghua Zhong Liu Za Zhi. 2014 Dec 23;36(12):916-21. doi: 10.3760/cma.j.issn.0253-3766.2014.12.008. Chinese.

PMID:
25623766
20.

Treatment, prognostic markers and survival in thymic neuroendocrine tumours. a study from a single tertiary referral centre.

Crona J, Björklund P, Welin S, Kozlovacki G, Oberg K, Granberg D.

Lung Cancer. 2013 Mar;79(3):289-93. doi: 10.1016/j.lungcan.2012.12.001. Epub 2013 Jan 1.

PMID:
23286964

Supplemental Content

Support Center